USANA Health Sciences, Inc.
USNA
$33.10
$0.140.43%
09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | 10.61M | 10.43M | 16.54M | 16.77M | 11.35M |
Total Depreciation and Amortization | 5.56M | 5.70M | 5.08M | 4.87M | 5.16M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 4.77M | -3.54M | 7.56M | 7.71M | 4.93M |
Change in Net Operating Assets | 8.59M | -4.60M | -11.49M | -3.33M | 803.00K |
Cash from Operations | 29.53M | 7.99M | 17.68M | 26.02M | 22.23M |
Capital Expenditure | -2.40M | -2.67M | -3.20M | -7.32M | -1.45M |
Sale of Property, Plant, and Equipment | 61.00K | 0.00 | 3.00K | 2.00K | 0.00 |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.00 | 1.13M | -870.00K | 0.00 | 0.00 |
Cash from Investing | -2.34M | -1.55M | -4.07M | -7.32M | -1.45M |
Total Debt Issued | -2.00K | 154.00K | 537.00K | 792.00K | 0.00 |
Total Debt Repaid | 3.00K | -1.48M | -- | 0.00 | 0.00 |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -79.00K | -31.00K | -12.48M | -134.00K | -11.64M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
Cash from Financing | -78.00K | -1.35M | -11.95M | 658.00K | -11.64M |
Foreign Exchange rate Adjustments | 5.45M | -1.02M | -3.81M | 4.06M | -2.26M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 32.57M | 4.07M | -2.14M | 23.42M | 6.88M |